Client News

Roquefort Therapeutics plc: Investor Presentation
Home / Client News / Roquefort Therapeutics plc: Investor Presentation

Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class drugs in the high value and high growth oncology segment, is pleased to announce that Executive Chairman Stephen West and CEO Ajan Reginald will give a live presentation following completion of the Acquisition of Oncogeni via the Investor Meet Company platform on Thursday 22 September at 2.00pm BST.


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This